help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Samuelsson, M. K. R.
Right arrow Articles by Okret, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samuelsson, M. K. R.
Right arrow Articles by Okret, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DEXAMETHASONE
*DOXYCYCLINE
*RU-486
Medline Plus Health Information
*Steroids
Molecular Endocrinology 13 (11): 1811-1822
Copyright © 1999 by The Endocrine Society

p57Kip2, a Glucocorticoid-Induced Inhibitor of Cell Cycle Progression in HeLa Cells

Magnus K. R. Samuelsson, Ahmad Pazirandeh, Behrous Davani and Sam Okret

Department of Medical Nutrition Karolinska Institute Huddinge University Hospital, Novum F60 SE-141 86 Huddinge, Sweden

Glucocorticoids exert antiproliferative effects on a number of cell types, including the HeLa cervical carcinoma cell line. However, the mechanism responsible for the antiproliferative effect is poorly understood. In this report we have investigated the role of the recently identified cyclin-dependent kinase inhibitor (CDI) p57Kip2 in the antiproliferative effect conferred by glucocorticoids. When HeLa cells were treated with the synthetic glucocorticoid dexamethasone (DEX), the doubling time of exponentially growing cells increased 2-fold. Within 11 h of DEX treatment, this was accompanied by an accumulation of cells in the G1 phase of the cell cycle with a corresponding decreased proportion of cells in the S phase and decreased CDK2 activity. DEX treatment of the HeLa cells dramatically induced the protein and mRNA expression of the CDI p57Kip2. This induction was seen within 4 h of DEX treatment, preceding a major DEX-induced accumulation of cells in the G1 phase. DEX-induced mRNA expression of p57Kip2 did not require de novo protein synthesis, and the transcription of the p57Kip2 gene was increased as determined by a run-on transcription assay. Furthermore, DEX induction of p57Kip2 was not a consequence of the cell cycle arrest, since other growth inhibition signals did not result in strong p57Kip2 induction. Overexpression of p57Kip2 using HeLa cells stably transfected with a tetracycline-inducible vector showed that p57Kip2 is sufficient to reconstitute an antiproliferative effect similar to that seen in DEX-treated cells. Selective p57Kip2 expression by the tetracycline analog doxycycline to levels comparable to those observed on DEX induction resulted in a 1.7-fold increase in the doubling time and a shift of HeLa cells to the G1 phase as well as a decrease in CDK2 activity. Taken together, these results suggest that glucocorticoid treatment directly induces transcription of the p57Kip2 gene and that the p57Kip2 protein is involved in the glucocorticoid-induced antiproliferative effect.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
Y.-K. Kim, J. Yu, T. S. Han, S.-Y. Park, B. Namkoong, D. H. Kim, K. Hur, M.-W. Yoo, H.-J. Lee, H.-K. Yang, et al.
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer
Nucleic Acids Res., April 1, 2009; 37(5): 1672 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. J. Jin, Y. Lho, Y. Wang, M. Ao, M. P. Revelo, S. W. Hayward, M. L. Wills, S. K. Logan, P. Zhang, and R. J. Matusik
Down-regulation of p57Kip2 Induces Prostate Cancer in the Mouse
Cancer Res., May 15, 2008; 68(10): 3601 - 3608.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kaur, J. E. Chivers, M. A. Giembycz, and R. Newton
Long-Acting 2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells
Mol. Pharmacol., January 1, 2008; 73(1): 203 - 214.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
V. C Dhulipala, W. V Welshons, and C. S Reddy
Cell cycle proteins in normal and chemically induced abnormal secondary palate development: a review
Human and Experimental Toxicology, November 1, 2006; 25(11): 675 - 682.
[Abstract] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Rothschild, X. Zhao, A. Iavarone, and A. Lasorella
E Proteins and Id2 Converge on p57Kip2 To Regulate Cell Cycle in Neural Cells.
Mol. Cell. Biol., June 1, 2006; 26(11): 4351 - 4361.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L.-G. Bladh, J. Liden, A. Pazirandeh, I. Rafter, K. Dahlman-Wright, S. Nilsson, and S. Okret
Identification of Target Genes Involved in the Antiproliferative Effect of Glucocorticoids Reveals a Role for Nuclear Factor-{kappa}B Repression
Mol. Endocrinol., March 1, 2005; 19(3): 632 - 643.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Kamura, T. Hara, S. Kotoshiba, M. Yada, N. Ishida, H. Imaki, S. Hatakeyama, K. Nakayama, and K. I. Nakayama
Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation
PNAS, September 2, 2003; 100(18): 10231 - 10236.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. K. Greenberg, J. Hu, S. Basu, J. Hay, J. Reibman, T.-a. Yie, K. M. Tchou-Wong, W. N. Rom, and T. C. Lee
Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators
Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 320 - 328.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Consten, E.D. Keuning, J. Bogerd, M.A. Zandbergen, J.G.D. Lambert, J. Komen, and H.J.Th. Goos
Sex Steroids and Their Involvement in the Cortisol-Induced Inhibition of Pubertal Development in Male Common Carp, Cyprinus carpio L
Biol Reprod, August 1, 2002; 67(2): 465 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
W. Y. Almawi and O. K. Melemedjian
Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor
J. Leukoc. Biol., January 1, 2002; 71(1): 9 - 15.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. H. RABBITT, G. G. LAVERY, E. A. WALKER, M. S. COOPER, P. M. STEWART, and M. HEWISON
Prereceptor regulation of glucocorticoid action by 11{beta}-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation
FASEB J, January 1, 2002; 16(1): 36 - 44.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Nishimura, N. Nonomura, E. Satoh, Y. Harada, M. Nakayama, T. Tokizane, T. Fukui, Y. Ono, H. Inoue, M. Shin, et al.
Potential Mechanism for the Effects of Dexamethasone on Growth of Androgen-Independent Prostate Cancer
J Natl Cancer Inst, November 21, 2001; 93(22): 1739 - 1746.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. J. Shah, J. A. Iniguez-Lluhi, A. Romanelli, S. R. Kimball, and L. S. Jefferson
The Activated Glucocorticoid Receptor Modulates Presumptive Autoregulation of Ribosomal Protein S6 Protein Kinase, p70 S6K
J. Biol. Chem., January 18, 2002; 277(4): 2525 - 2533.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society